APVO101: Clinical Trials

1 trial of APVO101, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Completed 1

Follow APVO101: new trials by email Literature Review of APVO101 trials Research Report on APVO101

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Evaluation of a Recombinant Factor IX Product, APVO101, in Previously-Treated Pediatric Patients With Hemophilia B
APVO101 - Hemophilia B
Phase 3CompletedMedexus Pharma, Inc.212020-01-162024-05-16

Conditions studied

Hemophilia B (1)

Sponsors

Medexus Pharma, Inc. (1)

Countries

Brazil (1)  ·  Georgia (1)  ·  Moldova (1)  ·  South Africa (1)  ·  Turkey (Türkiye) (1)  ·  Ukraine (1)

Top investigators

Khaled Mohamed (1)